RE:FinancingMike, you know there's a 200 million plus float, not counting warrants. You can bet your last dollar that the majority are held non-retail. Going by the last raise, where they barely got $250K after a month, that too with an insider buy, tells me there's little chance of being any different this time without positive news. IMO, they don't have much of a cash runway left. Logic says they're waiting for the FDA to decide if the data is good enough. I would like to think it is, if between 20 to 30% CR at 450 days and with only two treatments. I'm sticking with logic instead of my gut (which is usually right) through the end of this month. After ten years of literally going nowhere, what's another two weeks.